Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bioton

Bioton?uq=kzBhZRuG
1989 FOUNDED
PUBLIC STATUS
501-600 EMPLOYEES
BIO STOCK SYMBOL
7 INVESTMENTS
$1.91 SHARE PRICE (As of Tuesday Closing)
Description

Provider of biotechnological research and development services intended to protect patients' health and improving the quality of their lives. The company's biotechnological research and development services include drug development and manufacturing, with its current core, innovative, clinically important medicinal products being recombinant human insulin and diet supplements, enabling patients to avail next generation insulin analogue.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Stock Exchange
WAR
Primary Office
  • Ul. Starościńska 5
  • Warszawa, 02-516
  • Poland

+48 22 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bioton’s full profile, request a free trial.

Bioton Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.88 - $1.95 $161M $1.95 -$0.02 117K 85.9M

Bioton Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 124,602 115,083 206,696 301,484
Revenue 95,725 95,725 70,327 88,168
EBITDA 9,900 9,900 5,064 (132,446)
Net Income (1,923) (1,923) (7,237) (138,620)
Total Assets 328,020 328,020 309,291 320,838
Total Debt 56,938 56,938 54,743 58,076
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bioton Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bioton‘s full profile, request access.

Request full access to PitchBook

Bioton Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 11-Jan-2013 000000000000000000 000.00 Drug Discovery
0000000000 (000000 24-Feb-2010 000000000000000000 00.000 Drug Delivery 0ł000000 0000000 00
000000000 000000 29-Feb-2008 000000000000000000 Pharmaceuticals
00000000000 14-Mar-2007 000000000000000000 000.00 Biotechnology
Indar 06-May-2006 Secondary Transaction - Open Market 00.000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Bioton Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 (000000 24-Feb-2010 000000000000000000 00.000 Completed
  • 000000
Indar 06-May-2006 Secondary Transaction - Open Market 00.000 Completed
To view this company’s complete exits history, request access »

Bioton Subsidiaries (3)

Company Name Industry Location Founded
Medipolis GMP Biotechnology Oulu, Finland 2001
000000 Pharmaceuticals Singapore, Singapore 0000
000000000 000000 Pharmaceuticals Milan, Italy 0000
To view this company’s complete subsidiary history, request access »

Bioton Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bioton‘s full profile, request access.

Request full access to PitchBook

Bioton Executive Team (4)

Name Title Board
Seat
Contact
Info
Sławomir Ziegert MD President & Chief Executive Officer
Jubo Liu Ph.D President of the Managing Board
Boguslaw Kocinski Director, Operations
Jerzy Barbachowski Director, Sales and Marketing

Bioton Board Members (7)

Name Representing Role Since Contact
Info
0000000 00000000–000000 Self Board Member 000 0000
0000000 00000000 00.0 Self Vice Chairman 000 0000
000000 000000000 Self Vice Chairman 000 0000
000000 00000000000 Self Chairman 000 0000
000000 00000 Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »